GlassScriptPhysician profile
Anne Clark
NPI 1609899871
$3,111.35
in general payments reported to CMS, 2019-2025
31 companies · $43.18 in 2025
The $43.18 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $995 · 2022: $370 · 2023: $840 · 2024: $864 · 2025: $43.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,747.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $547.31 | 2021-2024 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $320.37 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $301.60 | 2021-2022 | |
| Glaxosmithkline, LLC. | $167.40 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $165.58 | 2021-2024 | Jardiance, Mounjaro, Zepbound |
| Idorsia Pharmaceuticals US INC | $142.44 | 2022-2023 | Quviviq |
| Phathom Pharmaceuticals, INC. | $137.37 | 2024 | Voquezna |
| Pfizer INC. | $118.22 | 2021-2024 | |
| Exact Sciences Corporation | $116.64 | 2023-2024 | Cologuard Collection Kit |
| Abbott Laboratories | $97.05 | 2022-2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.73 | 2021-2023 | Jardiance |
| Amarin Pharma, INC. | $87.72 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.05 | 2022-2024 | |
| Boston Scientific Corporation | $66.92 | 2024-2025 | Wavewriter Alpha Prime 16, Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd |
| Insulet Corporation | $66.40 | 2023-2024 | Omnipod |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vbi Vaccine (Delaware) INC. | $66.02 | 2022 | |
| Novartis Pharmaceuticals Corporation | $65.29 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $61.09 | 2024 | Gardasil 9, Capvaxive, Gardasil |
| Abbvie INC. | $57.74 | 2023-2024 | |
| Dynavax Technologies Corporation | $55.38 | 2021-2022 | |
| Amgen INC. | $48.43 | 2021-2024 | Repatha, Otezla |
| Dexcom, INC. | $42.01 | 2021-2024 | Dexcom G6 Transmitter |
| Azurity Pharmaceuticals, INC. | $40.12 | 2023 | Edarbi |
| Otsuka America Pharmaceutical, INC. | $26.79 | 2023 | Rexulti |
| Ethicon US, LLC | $24.57 | 2022 | |
| Astellas Pharma US INC | $24.23 | 2024 | Veozah |
| Phadia US INC. | $23.52 | 2024 | Immunocap |
| Eisai INC. | $20.61 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $18.17 | 2023 | Evkeeza |
| Kowa Pharmaceuticals America, INC. | $15.53 | 2021 | |
| Evoke Pharma, INC. | $13.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.